Gilead Sciences | GILD - PE Price to Earnings

Stock Price
140.41
Daily Change
1.04 0.75%
Monthly
-6.41%
Yearly
25.49%
Q2 Forecast
130.22

Gilead Sciences reported 15.63 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
AbbVie 24.03 86.23 Dec/2025
Agios Pharmaceuticals 3.56 0.68 Sep/2025
ALKERMES 19.54 4.64 Dec/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amgen 25.31 15.82 Dec/2025
Biogen 14.02 4.63 Dec/2025
BioMarin Pharmaceutical 19.24 0.21 Dec/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
Gilead Sciences 15.63 0.08 Dec/2025
GlaxoSmithKline 11.15 0.29 Dec/2025
Glaxosmithkline 11.66 0.28 Dec/2025
Incyte 14.84 2.79 Dec/2025
J&J 23.62 0.86 Dec/2025
Merck 13.92 5.08 Dec/2025
Moderna 27.22 14.51 Jun/2023
Neurocrine Biosciences 835.47 802.2 Dec/2025
Novartis 17.85 2.11 Dec/2025
Pfizer 14.48 5.18 Dec/2025
PTC Therapeutics 9.98 3.25 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Sanofi 11.99 1.58 Dec/2025
Sarepta Therapeutics 27.27 0 Sep/2025
United Therapeutics 17.32 1.62 Dec/2025
Vertex Pharmaceuticals 26.15 2.22 Dec/2025